APSR2026-272

 
Late-Breaking
Submitted
Oral Presentation
AO27-002
 
 
https://storage.unitedwebnetwork.com/files/1285/1216609-46903-APSR-2026-272_439778.pptx
Format: PPTX Only
 
Format: PDF Only
06. Tuberculosis
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Cai Li * The First Affiliated Hospital of Chongqing Medical University Department of Respiratory and Critical Care Medicine Chongqing China
Yajuan Chen - The First Affiliated Hospital of Chongqing Medical University Department of Respiratory and Critical Care Medicine Chongqing China
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Cai
Li
yajuanchencqmu@sina.com
+8615215004058
31-40
China
Original Research
Diagnostic Value of Targeted Next-Generation Sequencing (tNGS) in Pleural Effusion for Tuberculous Pleurisy: A Real-World Retrospective Cohort Study
Maximum 25 words
Abstract Content
Tuberculous pleurisy (TBP) remains a significant global health concern, but current diagnostic methods for TBP have some limitation. Target Next-generation sequencing (NGS) has emerged as a powerful tool in molecular diagnosis, but its role in diagnosing TBP from pleural effusion remains to be fully explored. This study was to explore the diagnostic value of tNGS in pleural effusion for TBP.
This study retrospectively enrolled patients with exudative pleural effusion, who were divided into two cohorts: TBP and non-TBP. The TBP cohort was further subdivided into two subgroups: the confirmed TBP subgroup(cf-TBP), which was diagnosed according to the criteria of the World Health Organization (WHO), and the clinically diagnosed TBP subgroup(cd-TBP) did not meet the criteria recommended by the WHO but was diagnosed by clinical characteristics. Pleural effusion samples were subjected to Xpert, adenosine deaminase (ADA), tNGS test, or culture.
A total of 87 patients were finally enrolled, including 78 TBP and 9 non-TBP patients. Among TBP, the sensitivity of tNGS was 81.48%, which was higher than that of culture and Xpert test. The specificity of tNGS was 100%, which was not significantly different from that of culture, Xpert test and ADA test. TBP patients were further divided into 26 cf-TBP cases and 52 cd-TBP cases. In the cf-TBP subgroup, the sensitivity of tNGS was 88.89%, which was not significantly different from that of culture, Xpert test and ADA test. In contrast, the sensitivity of tNGS in cd-TBP patients was 77.78%, which was higher than that of culture and Xpert test.
The tNGS showed excellent sensitivity and specificity in diagnosis of TBP; especially in some TBP with negative culture or Xpert test, tNGS showed favorable sensitivity.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Targeted Next-Generation Sequencing, tuberculous pleurisy, diagnostic performance
maximum 3 keywords and no abbreviations, separated by commas
None
280